Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6RU6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,437
Award facts
- Contract value 100% obligated
- $29,437.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,437.08 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with an ultimate completion date of December 24, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound (tirzepatide) is a GLP-1 receptor agonist used in diabetes and weight management treatments, reflecting the agency's continued procurement of specialty pharmaceutical products for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of medical supply contracts with the Defense Logistics Agency, supplying medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The company's role as a prime vendor demonstrates its established capability to meet federal medical procurement requirements and support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6RU6?
SPE2DR26F6RU6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F6RU6 worth?
The government has obligated $29,437 on SPE2DR26F6RU6.
Is contract SPE2DR26F6RU6 an order under another contract?
Yes. SPE2DR26F6RU6 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RU6 competed?
The extent of competition for SPE2DR26F6RU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award